Abstract：ObjectiveTo explore the clinical effect of Qijiao Shengbai Capsules on leukopenia in lung cancer patients after radiotherapy,and improvement of the quality of life in these patients after medication.MethodsFrom July 2014 to March 2017,102 patients with lung cancer admitted into our hospital were enrolled.All patients were performed with radiotherapy.Using the random grouping method,they were divided into the research group(n＝51)and control group(n＝51).The patients in the control group were provided with routine nutritional support,symptomatic treatment,and thoracic and abdominal drainage.In the research group,oral administration of Qijiao Shengbai Capsules on the first day after radiotherapy was added besides the same treatment in the control group.During hospitalization,blood test once per week was necessary.The incidence of myelosuppression and changes of white blood cell count before and after radiotherapy were compared between the two groups.ResultsIn the research group,the incidence of myelosuppression was 17.64%,which was much lower than that in the control group(68.63%),and the white blood cell count in the research group was greatly increased compared with that in the control group,which was displayed a statistical difference(P＜0.05).ConclusionFor lung cancer patients performed with radiotherapy,application of Qijiao Shengbai Capsules can obtain a favorable control effect on leukopenia and decrease the incidence of myelosuppression,which is of great importance on promoting rehabilitation of patients.
陈波;吴文杰. 芪胶升白胶囊对肺癌放疗患者白细胞减少的效果和对生存质量的影响分析[J]. 中国当代医药, 2017, 24(32): 53-55.
CHEN Bo;WU Wen-jie. Effect of Qijiao Shengbai Capsules on leukopenia in lung cancer patients after radiotherapy and its influence on quality of life. 中国当代医药, 2017, 24(32): 53-55.
京公网安备 11010502046607号